References
- Affordable Care Act. (2010). Patient protection and affordable care act. Public Law, 111–148.
- Arasteh, K., Des Jarlais, D. C., & Perlis, T. E. (2008). Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend, 95(1-2), 54–61. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2007.12.008
- Arnold, E. A., Hazelton, P., Lane, T., Christopoulos, K. A., Galindo, G. R., Steward, W. T., & Morin, S. F. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One, 7(7), e40603. https://doi.org/https://doi.org/10.1371/journal.pone.0040603
- Becasen, J. S., Denard, C. L., Mullins, M. M., Higa, D. H., & Sipe, T. A. (2019). Estimating the prevalence of HIV and sexual behaviors among the US transgender population: A systematic review and meta-analysis, 2006–2017. American Journal of Public Health, 109(1), e1–e8. https://doi.org/https://doi.org/10.2105/AJPH.2018.304727
- Blackstock, O. J., Moore, B. A., Berkenblit, G. V., Calabrese, S. K., Cunningham, C. O., Fiellin, D. A., Patel, V. V., Phillips, K. A., Tetrault, J. M., Shah, M., & Edelman, E. J. (2016). A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. Journal of General Internal Medicine, 32(1), 62–70. https://doi.org/https://doi.org/10.1007/s11606-016-3903-z
- Calabrese, S. K., Krakower, D. S., & Mayer, K. H. (2017). Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities. American Journal of Public Health, 107(12), 1883–1889. https://doi.org/https://doi.org/10.2105/AJPH.2017.304061
- Centers for Disease Control & Prevention (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline.
- Cohen, M. A., Cozza, K. L., Bourgeois, J. A., Moghimi, Y., Douaihy, A. (2016). The role of psychiatrists in HIV prevention. Psychiatric Times Web site. https://www.psychiatrictimes.com/view/role-psychiatrists-hiv-prevention. Published
- Conniff, J., & Evensen, A. (2016). Preexposure prophylaxis (PrEP) for HIV prevention: The primary care perspective. Journal of the American Board of Family Medicine, 29(1), 143–151. https://doi.org/https://doi.org/10.3122/jabfm.2016.01.150223
- Druss, B. G., & Rosenheck, R. A. (1998). Mental disorders and access to medical care in the United States. The American Journal of Psychiatry, 155(12), 1775–1777. https://doi.org/https://doi.org/10.1176/ajp.155.12.1775
- Eaton, L. A., Driffin, D. D., Bauermeister, J., Smith, H., & Conway-Washington, C. (2015). Minimal awareness and stalled uptake of Pre-Exposure Prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men. AIDS Patient Care STDS, 29(8), 423–429. https://doi.org/https://doi.org/10.1089/apc.2014.0303
- Egan, J. E., Casadonte, P., Gartenmann, T., Martin, J., McCance-Katz, E. F., Netherland, J., Renner, J. A., Weiss, L., Saxon, A. J., & Fiellin, D. A. (2010). The Physician Clinical Support System-Buprenorphine (PCSS-B): A novel project to expand/improve buprenorphine treatment. Journal of General Internal Medicine, 25(9), 936–941. https://doi.org/https://doi.org/10.1007/s11606-010-1377-y
- Golomb, B. A., Pyne, J. M., Wright, B., Jaworski, B., Lohr, J. B., & Bozzette, S. A. (2000). The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv.), 51(6), 766–773. https://doi.org/https://doi.org/10.1176/appi.ps.51.6.766
- Hammack, P. L., Meyer, I. H., Krueger, E. A., Lightfoot, M., & Frost, D. M. (2018). HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: A national probability sample of three birth cohorts. PLoS One, 13(9), e0202806. https://doi.org/https://doi.org/10.1371/journal.pone.0202806
- Han, B. H., Duncan, D. T., Arcila-Mesa, M., & Palamar, J. J. (2020). Co-occurring mental illness, drug use, and medical multimorbidity among lesbian, gay, and bisexual middle-aged and older adults in the United States: A nationally representative study. BMC Public Health, 20(1), 1123. https://doi.org/https://doi.org/10.1186/s12889-020-09210-6
- Havens, J. P., Scarsi, K. K., Sayles, H., Klepser, D. G., Swindells, S., & Bares, S. H. (2019). Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States. Open Forum Infectious Diseases, 6(10), ofz365.
- Health Resources and Services Administration. (2019). Ending the HIV epidemic: A plan for America.
- HIV Surveillance Report. (2018). Centers for Disease Control and Prevention. HIV Surveillance Report, vol. 30. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2019.
- Hughes, E., Bassi, S., Gilbody, S., Bland, M., & Martin, F. (2016). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: A systematic review and meta-analysis. The Lancet. Psychiatry, 3(1), 40–48. https://doi.org/https://doi.org/10.1016/S2215-0366(15)00357-0
- Kanny, D., Jeffries, W. L., Chapin-Bardales, J., Denning, P., Cha, S., Finlayson, T., & Wejnert, C., National HIV Behavioral Surveillance Study Group. (2019). Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men – 23 urban areas, 2017. MMWR. Morbidity and Mortality Weekly Report, 68(37), 801–806. https://doi.org/https://doi.org/10.15585/mmwr.mm6837a2
- Knudsen, H. K., Cook, J., Lofwall, M. R., Walsh, S. L., Studts, J. L., & Havens, J. R. (2017). A mixed methods study of HIV-related services in buprenorphine treatment. Substance Abuse Treatment, Prevention, and Policy, 12(1), 37. https://doi.org/https://doi.org/10.1186/s13011-017-0122-5
- Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS and Behavior, 18(9), 1712–1721. https://doi.org/https://doi.org/10.1007/s10461-014-0839-3
- Landovitz, R. (2020). HPTN 083 interim results: Pre-exposure prophylaxis containing long-acting injectable cabotegravir is safe and highly effective for cisgender men and transgender women who have sex with men. 23rd International AIDS Conference; July 8, Virtual.
- Mackesy-Amiti, M. E., Fendrich, M., & Johnson, T. P. (2010). Symptoms of substance dependence and risky sexual behavior in a probability sample of HIV-negative men who have sex with men in Chicago. Drug and Alcohol Dependence, 110(1/2), 38–43. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2010.01.016
- Majer, J. M., Komer, A. C., & Jason, L. A. (2015). Psychiatric severity and HIV-risk sexual behaviors among persons with substance use disorders. Journal of Dual Diagnosis, 11(1), 3–11. https://doi.org/https://doi.org/10.1080/15504263.2014.990802
- Mark, T. L., Olesiuk, W., Ali, M. M., Sherman, L. J., Mutter, R., & Teich, J. L. (2018). Differential reimbursement of psychiatric services by psychiatrists and other medical providers. Psychiatr (Serv.), 69(3), 281–285. https://doi.org/https://doi.org/10.1176/appi.ps.201700271
- Marshall, B. D., Prescott, M. R., Liberzon, I., Tamburrino, M. B., Calabrese, J. R., & Galea, S. (2013). Posttraumatic stress disorder, depression, and HIV risk behavior among Ohio Army National Guard Soldiers. Journal of Traumatic Stress, 26(1), 64–70. https://doi.org/https://doi.org/10.1002/jts.21777
- Mayer, K. H., Agwu, A., & Malebranche, D. (2020). Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Advances in Therapy, 37(5), 1778–1811. https://doi.org/https://doi.org/10.1007/s12325-020-01295-0
- Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., Wong, P., Ebrahimi, R., Zhong, L., Mathias, A., Callebaut, C., Collins, S. E., Das, M., McCallister, S., Brainard, D. M., … Hare, C. B. (2020). Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. The Lancet, 396(10246), 239–254. https://doi.org/https://doi.org/10.1016/S0140-6736(20)31065-5
- Meade, C. S., Bevilacqua, L. A., & Key, M. D. (2012). Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV. AIDS and Behavior, 16(8), 2267–2271. https://doi.org/https://doi.org/10.1007/s10461-012-0203-4
- Meade, C. S., & Sikkema, K. J. (2005). HIV risk behavior among adults with severe mental illness: A systematic review. Clinical Psychology Review, 25(4), 433–457. https://doi.org/https://doi.org/10.1016/j.cpr.2005.02.001
- Meade, C. S., & Sikkema, K. J. (2007). Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Mental Health Journal, 43(2), 153–169. https://doi.org/https://doi.org/10.1007/s10597-006-9071-6
- Metzger, D. S., Donnell, D., Celentano, D. D., Jackson, J. B., Shao, Y., Aramrattana, A., Wei, L., Fu, L., Ma, J., Lucas, G. M., Chawarski, M., Ruan, Y., Richardson, P., Shin, K., Chen, R. Y., Sugarman, J., Dye, B. J., Rose, S. M., Beauchamp, G., & Burns, D. N. (2015). Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058. Journal of Acquired Immune Deficiency Syndromes, 68(5), 554–561. https://doi.org/https://doi.org/10.1097/QAI.0000000000000510
- Miltz, A. R., Rodger, A. J., Lepri, A. C., Sewell, J., Nwokolo, N. C., Allan, S., Scott, C., Ivens, D., Lascar, M., Speakman, A., Phillips, A. N., Sherr, L., Collins, S., Elford, J., & Lampe, F. C, for the AURAH Study Group. (2020). Investigating conceptual models for the relationship between depression and condomless sex among gay, bisexual, and other men who have sex with men: Using structural equation modelling to assess mediation. AIDS and Behavior, 24(6), 1793–1806. https://doi.org/https://doi.org/10.1007/s10461-019-02724-0
- Mojtabai, R., & Olfson, M. (2018). Management of Common Medical Conditions by Office-Based Psychiatrists. Psychiatric Services (Washington, D.C.)), 69(4), 410–423. https://doi.org/https://doi.org/10.1176/appi.ps.201700255
- Morgan, E., Ryan, D. T., Newcomb, M. E., & Mustanski, B. (2018). High rate of discontinuation may diminish PrEP coverage among young men who have sex with men. AIDS and Behavior, 22(11), 3645–3648. https://doi.org/https://doi.org/10.1007/s10461-018-2125-2
- Newville, H., Sorensen, J. L., Hatch-Maillette, M., & Calsyn, D. A. (2018). Temporal relationship of sex risk behaviors and substance use severity among men in substance use treatment. Journal of Sex Research, 55(8), 1056–1064. https://doi.org/https://doi.org/10.1080/00224499.2017.1321101
- Pandor, A., Kaltenthaler, E., Higgins, A., Lorimer, K., Smith, S., Wylie, K., & Wong, R. (2015). Sexual health risk reduction interventions for people with severe mental illness: a systematic review. BMC Public Health, 15, 138. https://doi.org/https://doi.org/10.1186/s12889-015-1448-4
- Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP Awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267. https://doi.org/https://doi.org/10.1007/s10461-016-1625-1
- Pleuhs, B., Quinn, K. G., Walsh, J. L., Petroll, A. E., & John, S. A. (2020). Health care provider barriers to HIV pre-exposure prophylaxis in the United States: A systematic review. AIDS Patient Care STDS, 34(3), 111–123.
- Poteat, T. C., & Radix, A. (2020). HIV Antiretroviral treatment and pre-exposure prophylaxis in transgender individuals. Drugs, 80(10), 965–972. https://doi.org/https://doi.org/10.1007/s40265-020-01313-z
- Poteat, T., Scheim, A., Xavier, J., Reisner, S., & Baral, S. (2016). Global Epidemiology of HIV infection and related syndemics affecting transgender people. Journal of Acquired Immune Deficiency Syndromes, 72(Suppl 3), S210–S219.
- Reisner, S. L., Moore, C. S., & Asquith, A. (2019). High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. Journal of the International AIDS Society, 22(9), e25391.
- Riddell, J., Amico, K. R., & Mayer, K. H. (2018). HIV Preexposure prophylaxis: A review. JAMA, 319(12), 1261–1268. https://doi.org/https://doi.org/10.1001/jama.2018.1917
- Roll, J. M., Kennedy, J., Tran, M., & Howell, D. (2013). Disparities in unmet need for mental health services in the United States, 1997-2010. Psychiatric Services (Washington, D.C.).), 64(1), 80–82. https://doi.org/https://doi.org/10.1176/appi.ps.201200071
- Schmidt, H.-M A., McIver, R., Houghton, R., Selvey, C., McNulty, A., Varma, R., Grulich, A. E., & Holden, J. (2018). Nurse-led pre-exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained, pragmatic clinical trial. Sexual Health, 15(6), 595–597. https://doi.org/https://doi.org/10.1071/SH18076
- Serota, D. P., Rosenberg, E. S., Lockard, A. M., Rolle, C.-P M., Luisi, N., Cutro, S., Del Rio, C., Siegler, A. J., Sanchez, T. H., Sullivan, P. S., & Kelley, C. F. (2018). Beyond the biomedical: preexposure prophylaxis failures in a cohort of young black men who have sex with men in Atlanta, Georgia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 67(6), 965–970. https://doi.org/https://doi.org/10.1093/cid/ciy297
- Sevelius, J. M., Poteat, T., Luhur, W. E., Reisner, S. L., & Meyer, I. H. (2020). HIV Testing and PrEP use in a national probability sample of sexually active transgender people in the United States. Journal of Acquired Immune Deficiency Syndromes, Publish Ahead of Print.
- Sharma, M., Chris, A., Chan, A., Knox, D. C., Wilton, J., McEwen, O., Mishra, S., Grace, D., Rogers, T., Bayoumi, A. M., Maxwell, J., Shahin, R., Bogoch, I., Gilbert, M., & Tan, D. H. S. (2018). Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. BMC Health Services Research, 18(1), 513. https://doi.org/https://doi.org/10.1186/s12913-018-3324-2
- Siegler, A. J., Bratcher, A., & Weiss, K. M. (2019). Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. American Journal of Public Health, 109(9), 1216–1223. https://doi.org/https://doi.org/10.2105/AJPH.2019.305172
- Siegler, A. J., Bratcher, A., Weiss, K. M., Mouhanna, F., Ahlschlager, L., & Sullivan, P. S. (2018). Location location location: An exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. Annals of Epidemiology, 28(12), 858–864. https://doi.org/https://doi.org/10.1016/j.annepidem.2018.05.006
- Siegler, A. J., Mehta, C. C., & Mouhanna, F. (2018). Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States. Annals of Epidemiology, 2020 45, 24–31.e3.
- Sophus, A. I., & Mitchell, J. W. (2018). A review of approaches used to increase awareness of pre-exposure prophylaxis (PrEP) in the United States. AIDS and Behavior, 23(7), 1749–1770. https://doi.org/https://doi.org/10.1007/s10461-018-2305-0
- Sowers, W., Arbuckle, M., & Shoyinka, S. (2016). Recommendations for primary care provided by psychiatrists. Community Mental Health Journal, 52(4), 379–386. https://doi.org/https://doi.org/10.1007/s10597-015-9983-0
- Stewart, A. J., Theodore-Oklota, C., Hadley, W., Brown, L. K., Donenberg, G., & DiClemente, R., Project STYLE Study Group. (2012). Mania symptoms and HIV-risk behavior among adolescents in mental health treatment. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 41(6), 803–810. https://doi.org/https://doi.org/10.1080/15374416.2012.675569
- Su, D., Irwin, J. A., Fisher, C., Ramos, A., Kelley, M., Mendoza, D. A. R., & Coleman, J. D. (2016). Mental health disparities within the LGBT population: A comparison between transgender and nontransgender individuals. Transgender Health, 1(1), 12–20. https://doi.org/https://doi.org/10.1089/trgh.2015.0001
- Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., Castel, A. D., Yeung, H., Kramer, M., McCallister, S., & Siegler, A. J. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Annals of Epidemiology, 28(12), 833–840. https://doi.org/https://doi.org/10.1016/j.annepidem.2018.06.009
- Tetteh, R. A., Yankey, B. A., Nartey, E. T., Lartey, M., Leufkens, H. G., & Dodoo, A. N. (2017). Pre-exposure prophylaxis for hiv prevention: Safety concerns. Drug Safety, 40(4), 273–283. https://doi.org/https://doi.org/10.1007/s40264-017-0505-6
- Underhill, K., Morrow, K. M., Colleran, C. M., Holcomb, R., Operario, D., Calabrese, S. K., Galárraga, O., & Mayer, K. H. (2014). Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS One, 9(11), e112425. https://doi.org/https://doi.org/10.1371/journal.pone.0112425
- Vanderlip, E. R., Raney, L. E., & Druss, B. G. (2016). A framework for extending psychiatrists' roles in treating general health conditions. The American Journal of Psychiatry, 173(7), 658–663. https://doi.org/https://doi.org/10.1176/appi.ajp.2015.15070950
- Vearrier, L. (2019). The value of harm reduction for injection drug use: A clinical and public health ethics analysis. Disease–a–Monthly, 65(5), 119–141. https://doi.org/https://doi.org/10.1016/j.disamonth.2018.12.002
- Wainberg, M., & Dixon, L. (2017). Ending HIV, hepatitis B, and hepatitis C: what about people with severe mental illness? The Lancet. Psychiatry, 4(9), 651–653. https://doi.org/https://doi.org/10.1016/S2215-0366(17)30282-1
- West, J. C., Clarke, D. E., Duffy, F. F., Barber, K. D., Mojtabai, R., Mościcki, E. K., Kroeger Ptakowski, K., & Levin, S. (2016). Availability of mental health services prior to health care reform insurance expansions. Psychiatric Services (Washington, DC), 67(9), 983–989. https://doi.org/https://doi.org/10.1176/appi.ps.201500423
- Whiteman, K. L., Naslund, J. A., DiNapoli, E. A., Bruce, M. L., & Bartels, S. J. (2016). Systematic review of integrated general medical and psychiatric self-management interventions for adults with serious mental illness. Psychiatric Services (Washington, D.C.)), 67(11), 1213–1225. https://doi.org/https://doi.org/10.1176/appi.ps.201500521
- Zhang, C., McMahon, J., Fiscella, K., Przybyla, S., Braksmajer, A., LeBlanc, N., & Liu, Y. (2019). HIV Pre-exposure prophylaxis implementation cascade among health care professionals in the United States: Implications from a systematic review and meta-analysis. AIDS Patient Care STDS, 33(12), 507–527. https://doi.org/https://doi.org/10.1089/apc.2019.0119